SUVEN
Suven Life Sciences Limited
Healthcare Research, Analytics & Technology · ₹9,139 Cr market cap
A clinical-stage biopharmaceutical company engaged in the acquisition, development, and commercialization of novel therapeutics for treating neurodegenerative disorders. Suven Life Sciences operates across research, analytics, and technology platforms to advance its pipeline of investigational drugs targeting diseases affecting the nervous system. The company focuses on bringing innovative treatment solutions to patients suffering from neurological conditions through rigorous clinical development processes.
3
Tracked investors holding
1
Tracked moves
₹347
Share price
Latest activity
Recent moveIncreased
Jasti Property and Equity Holdings Private Limited increased its stake in Suven Life Sciences from 65.40% to 69.57% by acquiring 3,17,68,764 shares for ₹437.58 Cr at ₹137.74 apiece through a preferential allotment.
Top investors holding Suven Life Sciences Limited
Track smart money in Suven Life Sciences Limited
Get alerted when a top investor buys or sells.
Get started